TESAMORELIN 5MG

Tesamorelin is a synthetic analogue of Growth Hormone Releasing Hormone (GHRH) specifically developed to stimulate the body’s natural production of growth hormone. By selectively binding to GHRH receptors within the pituitary gland, Tesamorelin promotes physiological growth hormone release while maintaining the body’s normal endocrine feedback mechanisms.

Unlike recombinant growth hormone, Tesamorelin encourages endogenous hormone production, making it an important investigational peptide in studies of endocrine regulation, metabolic function, and healthy aging. Its selective mechanism has made it one of the most well-characterized GHRH analogues in modern peptide research.

Current scientific research investigates Tesamorelin for its potential role in:

• Growth hormone and IGF-1 signaling
• Metabolic regulation
• Body composition and visceral fat research
• Cellular recovery pathways
• Healthy aging investigations
• Endocrine physiology
• Energy metabolism
• Recovery-focused peptide research

Tesamorelin has also attracted significant interest because of its established clinical research history and its ability to stimulate growth hormone secretion without directly administering exogenous GH.

Key Research Areas

• Growth hormone secretion studies
• GHRH receptor activation research
• IGF-1 production investigations
• Metabolic regulation pathways
• Body composition research
• Visceral adipose tissue studies
• Recovery and regenerative investigations
• Healthy aging and longevity research

Product Specifications

• Peptide: Tesamorelin
• Strength: 5mg
• Format: Lyophilized powder
• Classification: Growth Hormone Releasing Hormone (GHRH) analogue
• Grade: Research-use peptide
• Purity: High-purity laboratory standard
• Storage: Store refrigerated at 2°C–8°C before reconstitution
• Intended Use: Scientific and laboratory research only

Why Researchers Study Tesamorelin

Tesamorelin is extensively researched because it selectively activates the GHRH receptor, promoting natural pulsatile growth hormone secretion and downstream IGF-1 production. Researchers investigate this mechanism to better understand endocrine physiology, metabolic regulation, and recovery-related biological pathways.

The peptide is also widely studied in models involving body composition, lipid metabolism, visceral adipose tissue, and healthy aging. Its selective receptor activity and extensive research background have established Tesamorelin as one of the leading GHRH analogues in peptide science.

Important Notice

This product is intended strictly for laboratory and scientific research purposes only. It is not intended for human consumption, medical treatment, or diagnostic use. Tesamorelin is supplied exclusively as an investigational research peptide and has not been approved for therapeutic or pharmaceutical applications outside authorized medical indications. Keep out of reach of children.